Is It Working? Evaluating The First Round Of Medicare Drug Price Negotiations
In the short and longer terms, the Medicare Drug Price Negotiation Program should be evaluated based on four categories of outcomes: beneficiary access, prices and spending, promotion of value, and effects on innovation.
Authors
- Laura Tollen
Institutions
- Health Affairs (US)
Publication Details
- Journal
- Health Affairs
- Published
- 2024-08-13
- DOI
- https://doi.org/10.1377/hlthaff.2024.00994
- Citations
- 1
- Primary Topic
- Healthcare Policy and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.13